Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of anastrozole in women with asymptomatic müllerian cancer.
del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. del Carmen MG, et al. Among authors: roche m. Gynecol Oncol. 2003 Dec;91(3):596-602. doi: 10.1016/j.ygyno.2003.08.021. Gynecol Oncol. 2003. PMID: 14675683 Clinical Trial.
A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.
Matulonis U, Campos S, Duska L, Fuller A, Berkowitz R, Gore S, Roche M, Colella T, Lee H, Seiden MV; Gynecologic Oncology Research Program at Dana Farber/Partners Cancer Care; Dana Farber-Harvard Cancer Care. Matulonis U, et al. Among authors: roche m. Gynecol Oncol. 2003 Nov;91(2):293-8. doi: 10.1016/s0090-8258(03)00496-7. Gynecol Oncol. 2003. PMID: 14599858 Clinical Trial.
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.
Penson RT, Campos SM, Seiden MV, Krasner C, Fuller AF Jr, Goodman A, Roche M, Willman A, Muzikansky A, Matulonis UA; Gynecologic Oncology Research Program at Dana Farber/Partners CancerCare. Penson RT, et al. Among authors: roche m. Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1035-41. doi: 10.1111/j.1525-1438.2005.00482.x. Int J Gynecol Cancer. 2005. PMID: 16343179 Free article. Clinical Trial.
Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.
Penson RT, Dizon DS, Cannistra SA, Roche MR, Krasner CN, Berlin ST, Horowitz NS, Disilvestro PA, Matulonis UA, Lee H, King MA, Campos SM. Penson RT, et al. Among authors: roche mr. J Clin Oncol. 2010 Jan 1;28(1):154-9. doi: 10.1200/JCO.2009.22.7900. Epub 2009 Nov 16. J Clin Oncol. 2010. PMID: 19917843 Clinical Trial.
1,310 results